Company Filing History:
Years Active: 1989
Title: The Innovations of Wilson Burgess
Introduction
Wilson Burgess is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA technology. His work has implications for both diagnostic applications and potential treatments for damaged blood vessels.
Latest Patents
Burgess holds a patent for a recombinant DNA vector encoding human endothelial cell growth factor. This invention involves the application of recombinant DNA technology to create cloning vehicles that encode the endothelial cell growth factor (ECGF) protein. The procedures outlined in the patent allow for the recovery of ECGF protein that is essentially free of other human-origin proteins. This product is particularly useful in various diagnostic applications and has potential therapeutic uses in treating damaged blood vessels and other endothelial cell-line structures.
Career Highlights
Wilson Burgess has been associated with Rorer Biotechnology Inc., where he has contributed to groundbreaking research and development in biotechnology. His work has positioned him as a key figure in the advancement of medical technologies that leverage genetic engineering.
Collaborations
Burgess has collaborated with notable colleagues, including Michael Jaye and Thomas Maciag. Their combined expertise has fostered an environment of innovation and discovery within their field.
Conclusion
Wilson Burgess's contributions to biotechnology through his patent on endothelial cell growth factor exemplify the impact of innovative thinking in medical science. His work continues to influence the development of treatments that can improve human health.